Thromboxane A2 and the development of hypertension in spontaneously hypertensive rats
- 1 January 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 146 (1), 129-135
- https://doi.org/10.1016/0014-2999(88)90494-3
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Delay of the initiation of hypertension in spontaneously hypertensive rats by CV-4151, a specific thromboxane A2 synthetase inhibitorEuropean Journal of Pharmacology, 1985
- Physiologic variables affecting thromboxane B2 production in human whole bloodThrombosis Research, 1985
- Glomerular synthesis of prostaglandins and thromboxane in spontaneously hypertensive rats.Hypertension, 1983
- Electrolyte and water balance in young spontaneously hypertensive rats.Hypertension, 1982
- Renal effects of pinane-thromboxane A2 and indomethacin in saline volume-expanded spontaneously hypertensive ratsEuropean Journal of Pharmacology, 1982
- Enhanced thromboxane A2 biosynthesis in the kidney of spontaneously hypertensive rats during development of hypertensionEuropean Journal of Pharmacology, 1981
- Some statistical methods useful in circulation research.Circulation Research, 1980
- Angiotensin-II-stimulated release of thromboxane a2 and prostacyclin (PGI2 ..) in isolated, perfused kidneys of spontaneously hypertensive ratsBiochemical Pharmacology, 1979
- SODIUM BALANCE AND STRUCTURAL VASCULAR CHANGES IN THE KIDNEY DURING DEVELOPMENT OF HYPERTENSION IN SPONTANEOUSLY HYPERTENSIVE RATSActa Medica Scandinavica, 1979
- Enhanced formation of PGI2, a potent hypotensive substance, by aortic rings and homogenates of the spontaneously hypertensive ratProstaglandins, 1978